• RAD21 confers poor prognosis and affects ovarian cancer sensitivity to PARP inhibitors through DNA damage repair.
    • Gou R, Li X, Dong H, Hu Y, Liu O, Liu J, Lin B.
    • Front Oncol. 2022 Jun 9;12:936550. doi: 10.3389/fonc.2022.936550.